Skip to main content

Bergmann glia: The silent architect shaping cerebellar cortex

In brief

Bergmann glia help organize cerebellar circuits, but disease roles remain unproven

This review describes how Bergmann glial cells support cerebellar surface folding and the proper function of neuronal circuits. Their impairment is linked to abnormalities in autism, synaptic plasticity, and vanishing white matter disease, making them candidate biomarkers and treatment targets. Whether they play a direct, disease-specific role still needs mechanistic testing.

Journal
Tissue & cell (Q2)
Published
15 November 2026
Study design
Narrative review / expert opinion
Evidence level
Level 5, Expert Opinion (CEBM 5)
Authors
Alina Simona Şovrea, Adina Bianca Boşca, Bogdan-Alexandru Gheban, Carmen Micu, Anne-Marie Constantin, Mihaela Jianu, et al.
PMID
43063880
DOI
10.1016/j.tice.2026.104134

Why clinicians should know about it

  • Picked for Embryology (top studies of the week, 22 November 2026): Cerebellar development, glial morphogenesis, and tissue organization

Abstract

The cerebellum is a brain structure that regulates motor functions and cognitive processes. Recent molecular and embryological studies have clarified its cellular development and the intercellular interactions that guide it. These studies have provided a framework for exploring molecular mechanisms underlying pattern formation, neurogenesis, fate determination, and prenatal and postnatal cell migration. This article focuses on the development, structure, identifying markers, and function of Bergmann glial cells (BGCs), which are crucial for the folding of the cerebellar surface, the proper functioning of the cerebellar neuronal circuit, and nervous pathology. BGCs offer a promising therapeutic target for central nervous system (CNS) disorders, with impaired cells being linked to abnormalities seen in autism spectrum disorder (ASD), long-term synaptic depression (LTD), and vanishing white matter (VWM). In conclusion, the evidence positions BGCs as active organizers of cerebellar circuitry and as candidate biomarkers and therapeutic targets whose disease-specific roles require further mechanistic validation.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.